Inspira Awarded $1.98M NIH Grant for Diabetes Therapy
Inspira Therapeutics was awarded a $1.98 million NIH grant to develop its polymeric biomaterial-based tolerogenic treatment for type 1 diabetes.
Anchor Biologics Wins the 2019 Cade Prize
The Cade Museum for Creativity and Invention announced Anchor Biologics as the first place winner of its 2019 Cade Prize. Anchor Biologics... Read More
